Marcel Muelbaier

6PUBLICATIONS
15CO-AUTHORS
MechanobiologyCheminformatics and quantitative structure-activity relationshipsProteomics and intermolecular interactions (excl. medical proteomics)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 17, 2020
A caged E3 ligase ligand for PROTAC-mediated protein degradation with light.

Cyrille S Kounde, Maria M Shchepinova, Charlie N Saunders

|Oct 04, 2019
Chemical proteomics reveals target selectivity of clinical Jak inhibitors in human primary cells.

H Christian Eberl, Thilo Werner, Friedrich B Reinhard

|Feb 27, 2019
PROTAC-Mediated Degradation of Bruton's Tyrosine Kinase Is Inhibited by Covalent Binding.

Christopher P Tinworth, Hannah Lithgow, Lars Dittus

|Jan 19, 2019
Fragment-Based Covalent Ligand Screening Enables Rapid Discovery of Inhibitors for the RBR E3 Ubiquitin Ligase HOIP.

Henrik Johansson, Yi-Chun Isabella Tsai, Ken Fantom

|Sep 07, 2017
Differential Kinobeads Profiling for Target Identification of Irreversible Kinase Inhibitors.

Lars Dittus, Thilo Werner, Marcel Muelbaier

|Jun 08, 2017
Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell Lines.

Douglas W Thomson, Anne J Wagner, Marcus Bantscheff

Pageof 1